Clinical efficacy and safety of nebulized prostacyclin in patients with sARs-CoV-2 (prospective comparative study)

Aim. In this study we evaluated clinical effectiveness and safety of nebulized prostacyclin in patients with Novel Coronavirus Disease (SARS-CoV-2). Materials and methods: We have included 44 male patients with moderate PCR confirmed SARS-CoV-2 infection in this study. Control group consisted of 23...

ver descrição completa

Detalhes bibliográficos

Principais autores:	K. V. Zhdanov, K. V. Kozlov, K. V. Kas’janenko, S. M. Zakharenko, V. S. Sukachev, N. I. L’vov, O. V. Mal’tsev, D. V. Lavrenchuk, I. I. Lapikov, V. V. Sharabhanov, R. M. Mukhtarov, M. A. Bulygin, V. G. Potapenko, E. A. Malikova, M. N. Nepomnjashchikh, B. B. Mursalov, A. R. Sheraliev, M. Yu. Pervakova, S. V. Lapin
Formato:	Artigo
Idioma:	Russo
Publicado em:	Journal Infectology 2020-08-01
coleção:	Журнал инфектологии
Assuntos:	covid-19 sars-cov-2 therapy prostacyclin
Acesso em linha:	https://journal.niidi.ru/jofin/article/view/1076
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!